Renaissance Technologies’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$336K Sell
10,167
-110,500
-92% -$3.65M ﹤0.01% 3001
2025
Q1
$4.85M Sell
120,667
-71,500
-37% -$2.87M 0.01% 1453
2024
Q4
$9.04M Sell
192,167
-52,200
-21% -$2.46M 0.01% 1080
2024
Q3
$12.9M Sell
244,367
-226,600
-48% -$12M 0.02% 916
2024
Q2
$25.5M Buy
470,967
+105,000
+29% +$5.69M 0.04% 497
2024
Q1
$25.7M Buy
365,967
+330,000
+918% +$23.1M 0.04% 526
2023
Q4
$3M Buy
+35,967
New +$3M ﹤0.01% 1691
2023
Q1
Sell
-73,667
Closed -$3.38M 4037
2022
Q4
$3.38M Buy
+73,667
New +$3.38M ﹤0.01% 1742
2021
Q4
Sell
-338,367
Closed -$12.1M 3952
2021
Q3
$12.1M Buy
338,367
+267,600
+378% +$9.56M 0.02% 919
2021
Q2
$1.4M Buy
+70,767
New +$1.4M ﹤0.01% 2488
2020
Q3
Sell
-71,067
Closed -$1.68M 3426
2020
Q2
$1.68M Buy
+71,067
New +$1.68M ﹤0.01% 2269
2020
Q1
Sell
-153,767
Closed -$1.63M 3493
2019
Q4
$1.63M Buy
153,767
+83,467
+119% +$885K ﹤0.01% 2416
2019
Q3
$800K Sell
70,300
-298,000
-81% -$3.39M ﹤0.01% 2681
2019
Q2
$4.14M Buy
368,300
+93,000
+34% +$1.05M ﹤0.01% 1914
2019
Q1
$2.23M Buy
275,300
+256,100
+1,334% +$2.07M ﹤0.01% 2252
2018
Q4
$121K Buy
+19,200
New +$121K ﹤0.01% 3206
2016
Q2
Sell
-184,479
Closed -$1.3M 3359
2016
Q1
$1.3M Sell
184,479
-334,799
-64% -$2.36M ﹤0.01% 2459
2015
Q4
$5.43M Buy
519,278
+299,578
+136% +$3.13M 0.01% 1417
2015
Q3
$1.47M Buy
219,700
+147,300
+203% +$986K ﹤0.01% 2175
2015
Q2
$487K Buy
72,400
+2,933
+4% +$19.7K ﹤0.01% 2728
2015
Q1
$471K Buy
+69,467
New +$471K ﹤0.01% 2617
2014
Q4
Sell
-498,161
Closed -$1.75M 2991
2014
Q3
$1.75M Buy
498,161
+240,624
+93% +$847K ﹤0.01% 1745
2014
Q2
$1.23M Buy
257,537
+69,470
+37% +$332K ﹤0.01% 1968
2014
Q1
$1.79M Sell
188,067
-147,200
-44% -$1.4M ﹤0.01% 1827
2013
Q4
$2.18M Buy
+335,267
New +$2.18M 0.01% 1709